EXOZ earnings date and last-quarter result: P/E -4.46. Updated 2026-07-23.
eXoZymes (EXOZ) Research Hub
eXoZymes (EXOZ) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.75 USD (-6.25%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.46, market cap 0.05B. This hub links to the full technical, earnings and options research available for EXOZ.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.75 USD (-6.25%) |
| 52-week range | 3.705 USD – 8.65 USD |
| Trend regime | Range |
| 14-day RSI | 13.9 (Oversold) |
| Trailing P/E | -4.46 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
Available research for EXOZ
Covered Call on EXOZ: how it works, illustrative setup around the real 3.75 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EXOZ: how it works, illustrative setup around the real 3.75 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EXOZ: how it works, illustrative setup around the real 3.75 USD price, max profit/loss, breakeven and when to use it. Educational.
EXOZ technical analysis: range, last 3.75 USD, RSI 13.9, 52w range 3.705 USD–8.65 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is EXOZ in?
eXoZymes (EXOZ) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is EXOZ in an uptrend or downtrend?
As of 2026-10-26, EXOZ is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EXOZ's trailing P/E ratio?
EXOZ's trailing P/E is -4.46, with a market cap of 0.05B. See the earnings research page for full valuation detail.